Stand Up To Cancer (SU2C) Company Profile

08:30 EDT 20th August 2018 | BioPortfolio

Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry’s resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about cancer prevention as well as progress being made in the fight against the disease. As SU2C’s scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, PhD, conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of the research progress.

News Articles [2119 Associated News Articles listed on BioPortfolio]

SU2C and Lustgarten partner to drive pancreatic cancer research

Not-for-profit organisation Stand Up To Cancer (SU2C) has formed a strategic alliance with US-based Lustgarten Foundation to support research to...Read More... The post SU2C and Lustgarten partner to ...

Stand Up To Cancer grants encourage 'innovation in collaboration'

(Entertainment Industry Foundation) SU2C is awarding $1.25 million to researchers within the SU2C community to collaborate across institutional and national lines on new research projects, to Claire F...

Stand Up To Cancer Takes New Approach to Multiple Myeloma, Focusing on Precursor Conditions

The SU2C Multiple Myeloma Dream Team will be led by Irene Ghobrial, MD, associate professor of medicine at Dana-Farber Cancer Institute (DFCI) in Boston Read more...

SU2C researchers find promising treatment strategy for stage 1-3 NSCL cancer patients

(Entertainment Industry Foundation) A new, innovative approach to lung cancer treatment, administration of immunotherapy prior to surgery yielded encouraging outcomes in findings from SU2C-CRI Dream T...

St. Baldrick's Foundation commits $8 million to support pediatric cancer dream team with SU2C

(Entertainment Industry Foundation) The work of the 2013 Stand Up To Cancer-St. Baldrick's Foundation Pediatric Cancer Dream Team will continue with a commitment of $8 million from St. Baldrick's Foun...

Stand Up To Cancer takes new approach to multiple myeloma focusing on precursor conditions

(Entertainment Industry Foundation) A $10 million SU2C Dream Team will revolutionize treatment of multiple myeloma, through early detection of precursor conditions MGUS & SMM, before they turn into f...

GEM Promega 3 Keyboard, with stand and music stand

£400.00 (0 Bids)End Date: Thursday May-17-2018 12:57:24 BSTBuy It Now for only: £599.00Buy It Now | Bid now | Add to watch list Biotech365 : GEM Promega 3 Keyboard, with stand and music st...

The Stand Up 2 Cancer Colorectal Dream Team

During AACR 2018, Dr. Diaz discusses the progress of his laboratory’s colorectal cancer research as part of the Stand Up 2 Cancer Colorectal Dream Team.

PubMed Articles [6177 Associated PubMed Articles listed on BioPortfolio]

Colorectal cancer prevention in Europe - where do we stand?

Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?

To provide an overview of the clinical development of poly(ADP-ribose) polymerase inhibitors (PARPi) in breast cancer to date and to review existing challenges and future research directions.

Effects of bilateral swing-away grab bars on the biomechanics of stand-to-sit and sit-to-stand toilet transfers.

Kinetic characteristics of transfers to and from a toilet performed using bilateral grab bars are not fully quantified to inform grab bar design and configuration. The purpose of this study was to (1)...

The role of tyrosine kinase inhibitors (TKIs) as adjuvant treatment for renal cancer. Where do we stand today?

Clinical and radiological outcomes after stand-alone ALIF for single L5-S1 degenerative discopathy using a PEEK cage filled with hydroxyapatite nanoparticles without bone graft.

Recent improvements in cage designs with integral fixation and screw attachments have made stand-alone ALIF a viable option with several possible advantages. The aim of this study was to confirm the e...

Clinical Trials [8369 Associated Clinical Trials listed on BioPortfolio]

Sit-to-Stand Training for Survivors of Stroke in a Long-Term Care Setting

The purpose of this study is to see if providing training using a Sit-to-Stand protocol for residents of Long-Term Care Facilities who have had a stroke will increase their independence in...

Stand & Move at Work

A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.

A Mixed-methods Evaluation of Sit-stand Workstations in an Office Setting

The purpose of this study is to investigate whether a device that allows office workers to sit or stand whilst working can reduce their sitting time at work and improve their health over 8...

Stand Up and Move More

The purpose of the expanded study is to examine the effectiveness of a "Stand Up and Move More" intervention to reduce sedentary behavior in older adults from underserved communities.

Sit-to-stand Training in Stroke Patient

Background: Manual lifting is a common method to train the sit-to-stand, in which repetition is important. Alternate training regimen by mechanical device may be opted to avoid staff injur...

Companies [1544 Associated Companies listed on BioPortfolio]

Stand Up To Cancer (SU2C)

Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Indust...

Stand Up To Cancer

Stand Up To Cancer (SU2C) -- a program of the Entertainment Industry Foundation (EIF), a 501(c)3 charitable organization -- raises funds to hasten the pace of groundbreaking translational research tha...


M/s. Kalpdrum Enterprises

M/s. Kalpdrum Enterprises is a growing concern, with leaps and bounds. The only reason that can be attributed to its growth & performance is its strict adherence to quality products and services since...

Cancer for College

Cancer for College was formed in 1993 by two-time cancer survivor and double-amputee Craig Pollard. Cancer for College was created to provide hope and inspiration by providing college scholarships to ...

More Information about "Stand Up To Cancer (SU2C)" on BioPortfolio

We have published hundreds of Stand Up To Cancer (SU2C) news stories on BioPortfolio along with dozens of Stand Up To Cancer (SU2C) Clinical Trials and PubMed Articles about Stand Up To Cancer (SU2C) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stand Up To Cancer (SU2C) Companies in our database. You can also find out about relevant Stand Up To Cancer (SU2C) Drugs and Medications on this site too.

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record